GCP
ZOM

GSA Capital Partners’s Zomedica Corp. ZOM Stock Holding History

GSA Capital Partners’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,995,874
Closed -$438K – 2115
2024
Q2 		$438K Buy
2,995,874
+2,750,887
+1,123% +$412K 0.03% 1047
2024
Q1 		$36K Buy
+244,987
New +$34.3K ﹤0.01% 1542
2022
Q3 		– Sell
-1,272,480
Closed -$280K – 2024
2022
Q2 		$280K Buy
1,272,480
+44,421
+4% +$11.3K 0.04% 870
2022
Q1 		$414K Buy
1,228,059
+31,377
+3% +$10.3K 0.06% 670
2021
Q4 		$367K Buy
+1,196,682
New +$539K 0.05% 804
2021
Q3 		– Sell
-103,232
Closed -$86K – 1928
2021
Q2 		$86K Buy
+103,232
New +$96.2K 0.01% 1255

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

GSA Capital Partners's ZOM Position: Q3 2024 in Review

GSA Capital Partners sold out of Zomedica Corp. (ZOM) in Q3 2024, closing a stake of 2,995,874 shares — an estimated $438K sold.

GSA Capital Partners first reported a position in ZOM in Q2 2021 and held it in 6 quarters. The position peaked at $438K in Q2 2024. 85 funds tracked by Wall St. Rank hold ZOM as of Q3 2024.

  • GSA Capital Partners reported no remaining Zomedica Corp. position as of Q3 2024 after selling out during the quarter.
  • GSA Capital Partners sold 2,995,874 Zomedica Corp. shares in Q3 2024, an estimated $438K.
  • GSA Capital Partners first reported a position in Zomedica Corp. in Q2 2021 and held it in 6 quarters.
  • GSA Capital Partners's Zomedica Corp. position peaked at $438K in Q2 2024.
  • 85 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2024.

Based on GSA Capital Partners's 13F filing for Q3 2024, filed 5 Nov 2024.